Back to Journals » OncoTargets and Therapy » Volume 14

Combination of Osimertinib and Anlotinib May Overcome the Resistance Mediated by in cis EGFR T790M-C797S in NSCLC: A Case Report

Total article views   HTML views PDF downloads Totals
5,839 Dovepress* 5,002+ 671 5,673
PubMed Central* 837 349 1,186
Totals 5,839 1,020 6,859
*Since 28 April 2021
Total mentioned Facebook Delicious Reddit Twitter Others
4 0 0 1 1 2

View citations on PubMed Central and Google Scholar